Inhibition of CCR3 activity in ATX-depleted tumors led to significant rescue of tumor growth and reduced eosinophil infiltration compared to vehicle-treated, ATX-depleted tumors (Fig. 5j,k). This evidence concerns the gene CCR3 and neoplasm.